COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses U Sahin, A Muik, E Derhovanessian, I Vogler, LM Kranz, M Vormehr, ... Nature 586 (7830), 594-599, 2020 | 1900 | 2020 |
REGN-COV2, a neutralizing antibody cocktail, in outpatients with Covid-19 DM Weinreich, S Sivapalasingam, T Norton, S Ali, H Gao, R Bhore, ... New England Journal of Medicine 384 (3), 238-251, 2021 | 1769 | 2021 |
Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies A Baum, BO Fulton, E Wloga, R Copin, KE Pascal, V Russo, S Giordano, ... Science 369 (6506), 1014-1018, 2020 | 1335 | 2020 |
Kyratsous CA J Hansen, A Baum, KE Pascal, V Russo, S Giordano, E Wloga, BO Fulton, ... Studies in humanized mice and convalescent humans yield a SARS-CoV-2 …, 2020 | 1064 | 2020 |
Structural and functional analysis of the D614G SARS-CoV-2 spike protein variant L Yurkovetskiy, X Wang, KE Pascal, C Tomkins-Tinch, TP Nyalile, Y Wang, ... Cell 183 (3), 739-751. e8, 2020 | 1053 | 2020 |
Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail J Hansen, A Baum, KE Pascal, V Russo, S Giordano, E Wloga, BO Fulton, ... Science 369 (6506), 1010-1014, 2020 | 1000 | 2020 |
BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans U Sahin, A Muik, I Vogler, E Derhovanessian, LM Kranz, M Vormehr, ... Nature 595 (7868), 572-577, 2021 | 661 | 2021 |
REGEN-COV antibody combination and outcomes in outpatients with Covid-19 DM Weinreich, S Sivapalasingam, T Norton, S Ali, H Gao, R Bhore, J Xiao, ... New England Journal of Medicine 385 (23), e81, 2021 | 625 | 2021 |
REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters A Baum, D Ajithdoss, R Copin, A Zhou, K Lanza, N Negron, M Ni, Y Wei, ... Science 370 (6520), 1110-1115, 2020 | 577 | 2020 |
Preference of RIG-I for short viral RNA molecules in infected cells revealed by next-generation sequencing A Baum, R Sachidanandam, A García-Sastre Proceedings of the National Academy of Sciences 107 (37), 16303-16308, 2010 | 494 | 2010 |
Subcutaneous REGEN-COV antibody combination to prevent Covid-19 MP O’Brien, E Forleo-Neto, BJ Musser, F Isa, KC Chan, N Sarkar, KJ Bar, ... New England Journal of Medicine 385 (13), 1184-1195, 2021 | 480 | 2021 |
Induction of type I interferon by RNA viruses: cellular receptors and their substrates A Baum, A García-Sastre Amino acids 38, 1283-1299, 2010 | 211 | 2010 |
The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies R Copin, A Baum, E Wloga, KE Pascal, S Giordano, BO Fulton, A Zhou, ... Cell 184 (15), 3949-3961. e11, 2021 | 202 | 2021 |
BNT162b2 induces SARS-CoV-2-neutralising antibodies and T cells in humans U Sahin, A Muik, I Vogler, E Derhovanessian, LM Kranz, M Vormehr, ... MedRxiv, 2020.12. 09.20245175, 2020 | 187 | 2020 |
Responses to acute infection with SARS-CoV-2 in the lungs of rhesus macaques, baboons and marmosets DK Singh, B Singh, SR Ganatra, M Gazi, J Cole, R Thippeshappa, ... Nature microbiology 6 (1), 73-86, 2021 | 179 | 2021 |
In Vivo Ligands of MDA5 and RIG-I in Measles Virus-Infected Cells S Runge, KMJ Sparrer, C Lässig, K Hembach, A Baum, A García-Sastre, ... PLoS pathogens 10 (4), e1004081, 2014 | 165 | 2014 |
ATPase‐driven oligomerization of RIG‐I on RNA allows optimal activation of type‐I interferon JR Patel, A Jain, Y Chou, A Baum, T Ha, A García‐Sastre EMBO reports 14 (9), 780-787, 2013 | 151 | 2013 |
Effect of subcutaneous casirivimab and imdevimab antibody combination vs placebo on development of symptomatic COVID-19 in early asymptomatic SARS-CoV-2 infection: a randomized … MP O’Brien, E Forleo-Neto, N Sarkar, F Isa, P Hou, KC Chan, BJ Musser, ... Jama 327 (5), 432-441, 2022 | 105 | 2022 |
Differential recognition of viral RNA by RIG-I A Baum, A García-Sastre Virulence 2 (2), 166-169, 2011 | 94 | 2011 |
Concurrent human antibody and TH1 type T-cell responses elicited by a COVID-19 RNA vaccine U Sahin, A Muik, E Derhovanessian, I Vogler, LM Kranz, M Vormehr, ... MedRxiv, 2020.07. 17.20140533, 2020 | 83 | 2020 |